|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
2004-8-10
|
|
pubmed:abstractText |
In patients with persistent atrial fibrillation (AF), the efficacy and safety of two anti-arrhythmic drugs in preventing the recurrence of AF after successful direct current (DC) cardioversion was prospectively assessed in a multi-centre double-blind, placebo-controlled, randomised trial using daily trans-telephonic monitoring.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0195-668X
|
|
pubmed:author |
pubmed-author:BauerPeterP,
pubmed-author:BreithardtGünterG,
pubmed-author:EngberdingRolfR,
pubmed-author:FetschThomasT,
pubmed-author:KochHans PHP,
pubmed-author:LuklJanJ,
pubmed-author:MeinertzThomasT,
pubmed-author:OeffMichaelM,
pubmed-author:Prevention of Atrial Fibrillation after Cardioversion Investigators,
pubmed-author:SeipelLudgerL,
pubmed-author:TrappeHans JHJ,
pubmed-author:TreeseNorbertN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1385-94
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15302102-Adolescent,
pubmed-meshheading:15302102-Adult,
pubmed-meshheading:15302102-Aged,
pubmed-meshheading:15302102-Aged, 80 and over,
pubmed-meshheading:15302102-Anti-Arrhythmia Agents,
pubmed-meshheading:15302102-Atrial Fibrillation,
pubmed-meshheading:15302102-Double-Blind Method,
pubmed-meshheading:15302102-Drug Therapy, Combination,
pubmed-meshheading:15302102-Electric Countershock,
pubmed-meshheading:15302102-Female,
pubmed-meshheading:15302102-Follow-Up Studies,
pubmed-meshheading:15302102-Humans,
pubmed-meshheading:15302102-Male,
pubmed-meshheading:15302102-Middle Aged,
pubmed-meshheading:15302102-Prospective Studies,
pubmed-meshheading:15302102-Quinidine,
pubmed-meshheading:15302102-Recurrence,
pubmed-meshheading:15302102-Sotalol,
pubmed-meshheading:15302102-Survival Analysis,
pubmed-meshheading:15302102-Treatment Outcome,
pubmed-meshheading:15302102-Verapamil
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
|
|
pubmed:affiliation |
Universitätsklinik Münster, Medizinische Klinik und Poliklinik C, D-48129, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
